Treatment of acute, symptomatic, proximal deep vein thrombosis with the oral, direct Factor Xa inhibitor rivaroxaban (BAY 59-7939) – the ODIXa-DVT dose-ranging study - Agnelli, G; Gallus, A; Goldhaber, S (Eur Heart J, 2006)
(Suppl)